Glucosamine HCl as a new carrier for improved dissolution behaviour: Effect of grinding

Colloids and Surfaces B: Biointerfaces

Volumn 81, Issue 1, 2010, Pages 96-109

  Al Hamidi, Hiba ^a,b   Edwards, Alison A ^a   Mohammad, Mohammad A ^b,c   Nokhodchi, Ali ^a,d  

^a MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

^b DAMASCUS UNIVERSITY   (Syrian Arab Republic)

^c IUST   (Syrian Arab Republic)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carbamazepine; Co grinding; Dissolution rate; Glucosamine HCl; Grinding time; Polymorphism

Indexed keywords

CARBAMAZEPINE; CO-GRINDING; DISSOLUTION RATE; GLUCOSAMINES; GRINDING TIME;

AMIDES; BALL MILLS; CRYSTALS; GRINDING (MACHINING); MIXTURES; ORGANIC SOLVENTS; POLYMORPHISM;

DISSOLUTION;

CARBAMAZEPINE; EXCIPIENT; GLUCOSAMINE;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG TRANSFORMATION; EXCIPIENT COMPATIBILITY; GRINDING; HYDROPHOBICITY; INFRARED SPECTROSCOPY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PHYSICAL PHASE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOLID STATE; SURFACE PROPERTY; X RAY POWDER DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; CARBAMAZEPINE; DRUG COMPOUNDING; EXCIPIENTS; GLUCOSAMINE; PARTICLE SIZE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TECHNOLOGY, PHARMACEUTICAL; X-RAY DIFFRACTION;

EID: 77956010839     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2010.06.028     Document Type: Article

References (48)

1. Abdou R.F., Megalla S.E., Moharram A.M., Abdel-Gawad K.M., Sherif T.H., El Syed Mahmood A.L., Lottfy A.E. J. Basic Microbiol. 1989, 29:131.
2. Otsuka M., Kaneniwa N. Chem. Pharm. Bull. 1984, 32:1071.
3. Ford G.W., Lewis J.T., O'Connell R.F. Phys. Rev. 1986, A34.
4. Takeuchi H., Handa T., Kawashima Y. J. Pharm. Pharmacol. 1987, 39:769.
5. Nystrom C., Westerberg M. J. Pharm. Pharmacol. 1986, 38:161.
6. Nozawa Y., Mizumoto T., Higashide F. Yakuzaigaku 1984, 44:134.
7. Moyano J.R., Gines J.M., Arias M.J., Rabasco A.M. Int. J. Pharm. 1995, 114:95.
8. Buckton G., Beezer A.E. Int. J. Pharm. 1992, 82:R7.
9. Yamaguchi G., Sakomoto K. Bull. Chem. Soc. Jpn. 1959, 32:1364.
10. Vadym N., Mochalin A.S., Shruti G., Yury G. Pharm. Res. 2009, 26:1365.
11. Kubo M., Oumi Y., Miura R., Stirling A., Miyamoto A., Kawasaki M., Yoshimoto M., Koinuma H. Phys. Rev. B. 1997, 56:13535.
12. Liversidge G.G., Cundy K.C. Int. J. Pharm. 1995, 125:91.
13. Sugimoto M., Okagaki T.S., Narisawa S., Koida Y., Nakajima K. Int. J. Pharm. 1998, 160:11.
14. Yamada H., Takahashi S., Fujita H., Kobayashi N., Okabe S. Dig. Dis. Sci. 1999, 44:889.
15. Camarada C.C., Dowless G. Ann. Pharmacol. Ther. 1998, 832:580.
16. Pujalte J.M., Llavore E.P., Ylescupidez F.R. Curr. Med. Res. Opin. 1980, 7:110.
17. Al-Hamidi H., Edwards A.A., Mohammad M.A., Nokhodchi A. Colloids Surf. B: Biointerf. 2010, 76:170.
18. Sarkari M., Brown J., Chen X., Swinnea S., Williams R.O., Johnston K.P. Int. J. Pharm. 2002, 243:17.
19. Moneghini M., Kikic I., Voinovich D., Perissutti B., Filipovic-Grcic J. Int. J. Pharm. 2001, 222:129.
20. Higuchi T., Connors K.A. Adv. Anal. Chem. Instrum. 1965, 4:117.
21. Khan K.A. J. Pharm. Pharmacol. 1975, 27:48.
22. Zingone G., Rubessa F. STP Pharma Sci. 1994, 4:122.
23. Barzegar-Jalali M., Valizadeh H., Siahi Shadbad M., Adibkia K., Mohammadi G., Farahani A., Arash Z., Nokhodchi A. Powder Technol. 2010, 197:150.
24. Atkinson R.M., Bedford C., Child K.J., Tomish E.G. Nature 1962, 193:588.
25. Liversidge G.G., Conzentino P. Int. J. Pharm. 1995, 125:309.
26. Barzegar-Jalali M., Valizadeh H., Dastmalchi S., Shadbada M., Barzegar-Jalali A., Adibkia K., Mohammadi G. Iranian J. Pharm. Res. 2007, 6:159.
27. Lee H., Park S., Sah H. Arch. Pharm. Res. 2005, 28:120.
28. York P., Ticehurst M.D., Osborn J.C., Roberts R.J., Rowe R.C. Int. J. Pharm. 1998, 174:179.
29. Bolourtchian N., Nokhodchi A., Dinarvand R. Daru 2001, 9:12.
30. Nokhodchi A., Bolourtchian N., Dinarvand R. J. Cryst. Growth 2005, 274:573.
31. G. Brittain, Physical characterization and pharmaceutical solids, Marcel Dekker, Inc., New York (1995) 93.
32. Anderson B.D., Flora K.P. Preparation of water-soluble compounds through salt formation. The Practice of Medicinal Chemistry 1996, Academic Press.
33. Blagden N., de Matas M., Gavan P.T., York P. Adv. Drug Deliv. Rev. 2007, 59:617.
34. Setnikari I., Cereda R., Pacini M.A., Revel L. Arzneimittel-Forschung/Drug Res. 1991, 41:147.
35. Remington The Science and Practice of Pharmacy 2005, Lippincott, Williams, and Wilkins, Philadelphia, PA, 1503. 21th ed.
36. Schultheiss N., Newman A. Cryst. Growth Des. 2009, 9:2950.
37. Jayasankar A., Somwangthanaroj A., Shao Z.J., Rodri{dotless}guez-Hornedo N. Pharm. Res. 2006, 23:2381.
38. Rustichelli C., Gamberini G., Ferioli V., Gamberini M.C., Ficarra R., Tommasini S. J. Pharm. Biomed. Anal. 2000, 23:41.
39. Grzesiak A.L., Lang M., Kim K., Matzger A.J. J. Pharm. Sci. 2003, 92:2260.
40. McMahon L.E., Timmins P., Williams A.C., York P. J. Pharm. Sci. 1996, 85:1064.
41. Krahn U., Mielck J.B. Pharm. Acta Helv. 1987, 62:247.
42. Lefebvre C., Guyot-Hermann A.M., Draguet-Brughmans M., Bouché R., Guyot J.C. Drug Dev. Ind. Pharm. 1986, 12:1913.
43. Lefebvre C., Guyot-Hermann A.M., Draguet-Brughmans M., Bouché R. Pharm. Acta Helv. 1987, 62:341.
44. A.D. Edwards, Thesis, Supercritical fluid precipitation and spray drying of drug polymer particles, University of Bradford, Bradford, UK, 2001.
45. Lowes M.M.J., Caira M.R., Lotter A.P., Van der Watt J.G. J. Pharm. Sci. 1987, 76:744.
46. Ceolin R., Toscnai S., Gardette M.F., Agafonov V., Dzyabchenko A., Bachet B. J. Pharm. Sci. 1997, 86:1062.
47. Gosselin P.M., Thibert R., Preda M., McMullena J.N. Int. J. Pharm. 2003, 252:225.
48. Kobayashi Y., Ito S., Itai S., Yamamoto K. Int. J. Pharm. 2000, 193:137.